arrow
S

Samson, Maxime

hopital universitaire pitie-salpetriere - aphp
H指数:0
被引数:32

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Tolerance of Cladribine for Non-Langerhans Cell Histiocytosis

克拉屈滨治疗非朗格汉斯细胞组织细胞增多症的有效性和耐受性

2026-01-010
PRE
Juvenile-Onset Mixed Connective Tissue Disease: A Multicenter Retrospective Cohort Study

青少年发病的混合性结缔组织病:一项多中心回顾性队列研究

2025-12-110
OAAI
Diffuse alveolar haemorrhage in antiphospholipid syndrome: a French series of 26 patients

抗磷脂综合征的弥漫性肺泡出血:一项来自法国的26例患者系列研究

2025-12-010
PRE
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile

Janus kinase与钙调神经磷酸酶抑制剂联合治疗抗-MDA5皮肌炎:无显著生存获益但安全性特征令人放心

2025-11-010
OAAI
Immediate versus gradual TocilizuMab discontinuAtion in GIant Cell Arteritis: protocol of the multicentre randomised open-label MAGICA trial

立即与逐步停用TocilizuMab治疗巨细胞动脉炎:多中心随机开放标签MAGICA试验方案

2025-10-070
OAAI
Comparative efficacy and safety of anakinra and canakinumab in patients with VEXAS syndrome – an international multicenter study

阿那白滞素(anakinra)和卡那单抗(canakinumab)在VEXAS综合征患者中的比较疗效与安全性——一项国际多中心研究

2025-09-220
OAAI
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX

阿扎胞苷治疗VEXAS综合征的疗效与安全性:FRENVEX小组的一项大规模回顾性研究

Blood
IF23.1
2025-05-190
PRE
Neurological manifestations in patients with VEXAS syndrome (vol 272, 181, 2025)

VEXAS综合征患者的神经系统表现(vol 272, 181, 2025)

2025-05-160
PRE
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors

糖皮质激素与糖皮质激素联合环磷酰胺治疗嗜酸性肉芽肿性多血管炎预后不良因素

2024-12-010
PRE
Prognostic value of 18 FDG-PET at diagnosis and follow-up in giant cell arteritis: An observational restrospective study
2024-08-018
PRE
BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre with score
2024-01-011
OAAI
Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor α in autoimmune hemolytic anemia and participate in Th17 polarization
2023-08-035
OAAI
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases
2023-04-0127
OAAI